20462 ⎘
Medicinal preparations containing organic active ingredients; Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E, prostaglandin F
COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS
#2FORMULATIONS
#3METHODS FOR IMPROVING COGNITIVE FUNCTION
#4CONTACT LENSES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING SLOW RELEASE OF GLAUCOMA TREATING DRUGS AND COMFORT ENHANCING DRUGS
#5Topical Ocular Insulin Delivery Enhanced by Prostaglandin Analogues
#6REDUCED DOSING REGIMENS FOR GLAUCOMA TREATMENT
#7HAIR REGROWTH TOPICAL COMPOSITION
#8MESENCHYMAL PROGENITOR CELLS FOR ENHANCING PARTIAL REPROGRAMMING OF TARGET CELLS
#9NEBULIZER KITS AND USES THEREOF
#10MISOPROSTOL FORMULATION FOR BUCCAL ADMINISTRATION
#11TOPICAL COMPOSITION COMPRISING A PROSTAGLANDIN ANALOGUE
#12USE OF GNRH ANTAGONISTS IN MAMMALS TO SYNCHRONIZE FOLLICULAR WAVE EMERGENCE
#13COMPOUND MEDICINE COMPOSITION FOR TREATING GLAUCOMA AND USE OF SAME
#14PROSTANOID RECEPTOR AGONISTS AS NON-TUBERCULOUS ANTI-MYCOBACTERIAL AGENTS
#15ROCK INHIBITORS AND USES THEREOF
#16LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT
#17PROSTAGLANDIN ANALOGS AND METHODS FOR SUSTAINED GLAUCOMA MANAGEMENT
#18COMPOSITIONS AND METHODS FOR TREATING EYES AND METHODS OF PREPARATION
#19COMPOSITIONS AND METHODS FOR DELIVERY OF OCULAR THERAPEUTICS
#20TOPICAL COMPOSITION
#21Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
#22METHODS AND COMPOSITIONS FOR THE TREATMENT OF HAIR LOSS
#23INDUSTRIAL PROCESS FOR THE PREPARATION OF HEXANOIC ACID, 6-(NITROOXY)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ETHYLAMINO)-7-OXO-2-HEPTEN-1-YL]-3,5-DIHYDROXYCYCLOPENTYL]-1-(2-PHENYLETHYL)-2-PROPEN-1-YL ESTER AND HIGH PURE PRODUCT
#24PROSTACYCLIN ANALOGUE FORMULATIONS
#25METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING LOSS AND/OR DISTORTION OF TASTE OR SMELL
#26TREPROSTINIL SOFT MIST INHALANT
#27D2O STABILIZED PHARMACEUTICAL FORMULATIONS
#28COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#29METHODS FOR TREATING HAIR LOSS AND NAIL BRITTLENESS, FRAGILITY, OR PITTING
#30ANTERIOR SEGMENT DRUG DELIVERY
#31INJECTABLE AND/OR SPRAYABLE, IN SITU POLYMERIZABLE COLLAGEN COMPOSITIONS FOR SUSTAINED DELIVERY OF THERAPEUTICS
#32DERMAL AND TRANSDERMAL ADMINISTRATION OF TREPROSTINIL AND SALTS THEREOF
#33IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
#34Diketopiperazine Microparticles with Defined Specific Surface Areas
#35CHANNEL MODULATORS
#36COMPOSITIONS AND METHODS FOR MUSCLE REGENERATION USING PROSTAGLANDIN E2
#37J-SERIES PROSTAGLANDIN-ETHANOLAMIDES AS NOVEL THERAPEUTICS FOR SKIN AND/OR ORAL DISORDERS
#38COMPOSITIONS AND METHODS FOR DELIVERY OF OCULAR THERAPEUTICS
#39TRANSDERMAL TREATMENT FOR ERECTILE DYSFUNCTION
#40TREPROSTINIL DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS
#41FORMULATIONS OF KINASE INHIBITORS AND PROSTANOIDS
#42IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
#43A TOPICAL GEL FORMULATION FOR SKIN AND MOUTH DISORDERS AND A PROCESS OF PREPARATION THEREOF
#44COMPOSITIONS AND METHODS FOR MUSCLE REGENERATION USING PROSTAGLANDIN E2
#45COMPOSITIONS AND USES THEREOF FOR TREATMENT OF NEUROLOGICAL DISORDERS
#46NITRIC OXIDE RELEASING PROSTAMIDE AS NEUROPROTECTIVE AGENT
#47METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS
#48TREATMENT OF HFPEF IN POST-MENOPAUSAL WOMEN WITH AN SGC STIMULATOR
#49METHODS AND COMPOSITIONS FOR REPRODUCTIVE MANAGEMENT OF SHEEP AND GOATS
#50PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE
#51Synergistic Compositions for Gynecological Procedures
#52CONTROLLED RELEASE PHARMACEUTICAL FORMULATIONS
#53FORMULATION FOR INCREASING HAIR GROWTH AND REDUCING HAIR THINNING
#54Contact lenses including medicaments and methods of making and using same including stabilizers of labile components such as drugs
#55INTRAOCULAR PRESSURE REDUCTION WITH INTRACAMERAL BIMATOPROST IMPLANTS
#56BIODEGRADABLE DRUG-POLYMER CONJUGATE
#57AGENT FOR TREATING OR PREVENTING GLAUCOMA INCLUDING A SULFONAMIDE COMPOUND AND ANOTHER DRUG
#58PHARMACEUTICAL FORMULATIONS OF TREPROSTINIL PRODRUGS AND METHODS OF USE THEREOF
#59COMBINATION THERAPY FOR PULMONARY HYPERTENSION
#60SUSTAINED-RELEASE IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE WITH EXTENDED DURATION OF EFFECT
#61INTRACAMERAL IMPLANT FOR TREATMENT OF AN OCULAR CONDITION
#62POLYMERIC IMPLANTS
#63METHOD OF TREATING A PATIENT DIAGNOSED WITH AN INTERSTITIAL LUNG DISEASE
#64METHOD OF TREATING A PATIENT DIAGNOSED WITH AN INTERSTITIAL LUNG DISEASE
#65METHODS AND COMPOSITIONS FOR THE TREATMENT OF HAIR LOSS
#66COMPOSITIONS AND TECHNIQUES FOR VAGINAL INSERTION
#67ANHYDROUS POLYMORPHS OF ANDROGEN RECEPTOR ANTAGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF
#68STABLE OPHTHALMIC COMPOSITION COMPRISING LATANOPROST
#69Topical Testosterone (T) for Promoting Hair Growth-Containing Formulations
#70PROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) COMPOUNDS AND METHODS OF USING THE SAME
#71NOVEL USE
#72LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT
#73PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE
#74Aqueous pharmaceutical compositions of prostaglandins
#75INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS
#76METHODS FOR TREATING PULMONARY HYPERTENSION
#77SUSTAINED-RELEASE IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE WITH EXTENDED DURATION OF EFFECT
#78Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
#79METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES
#80METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES
#81COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS
#82FORMULATIONS
#83PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF
#84METHODS FOR TREATING AND PHARMACEUTICAL COMPOSITIONS
#85COMPOSITIONS AND METHODS FOR TREATING EYES AND METHODS OF PREPARATION
#86PHARMACEUTICAL COMPOSITION FOR COMBINATION THERAPY COMPRISING MELATONIN AND PROSTAGLANDIN E2 FOR TREATING INTESTINAL EPITHELIAL INJURY AS AN ACTIVE INGREDIENT
#87TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH
#88METHODS AND COMPOSITIONS FOR THE TREATMENT OF HAIR LOSS
#89DUAL CAP SYSTEM FOR CONTAINER-CLOSURES TO MAINTAIN TIP STERILITY DURING SHELF STORAGE
#90OPHTHALMIC TOPICAL CREAM FORMULATIONS AND USES THEREOF
#91POSTERIOR CHAMBER PLACEMENT OF SUSTAINED RELEASE IMPLANT
#92COMBINATION THERAPY
#93PROSTAGLANDIN RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF A CORONAVIRUS INFECTION SUCH AS COVID-19
#94OPHTHALMIC COMPOSITIONS COMPRISING LATANOPROST FOR USE IN THE TREATMENT OF OCULAR DISEASES
#95COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIPID-RELATED DISORDERS
#96COMPOSITIONS FOR REDUCING HAIR LOSS AND/OR INCREASING HAIR REGROWTH
#97Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
#98USE OF HIGH MOLECULAR WEIGHT HYALURONIC ACID AS OCULAR TRANSPORTING VEHICLE
#99Ophthalmic gel compositions of bimatoprost and timolol and associated methods
#100USE OF CANNABINOIDS IN TREATING ANTI-DEPRESSANT-INDUCED FEMALE SEXUAL DYSFUNCTION
#101METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT
#102PRESERVATIVE-FREE OPHTHALMIC PHARMACEUTICAL EMULSION AND ITS APPLICATION
#103COMPOSITIONS AND METHODS FOR LOWERING INTRACRANIAL PRESSURE
#104FORMULATIONS FOR REDUCING HAIR LOSS AND/OR INCREASING HAIR REGROWTH
#105Enhanced penetration ophthalmic compositions of bimatoprost and timolol
#106METHODS OF TREATING OPHTHALMIC CONDITIONS WITH ENHANCED PENETRATION COMPOSITIONS OF BIMATOPROST AND TIMOLOL
#107COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#108GLAUCOMA TREATMENT VIA INTRACAMERAL OCULAR IMPLANTS
#109Pharmaceutical preparation containing pyridyl aminoacetic acid compound
#110TREPROSTINIL ILOPROST COMBINATION THERAPY
#111OSMOTIC DRUG DELIVERY SYSTEM
#112MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#113BIODEGRADABLE COMPOSITIONS AND IMPLANTS
#114OPHTHALMIC NANOEMULSION COMPOSITIONS
#115SMART WIRELESSLY DRIVEN CONTACT LENS FOR MEASURING INTRAOCULAR PRESSURE OF AND TREATING GLAUCOMA PATIENTS
#116Diketopiperazine Microparticles with Defined Specific Surface Areas
#117CHANNEL MODULATORS
#118DRUG DELIVERY METHODS, STRUCTURES, AND COMPOSITIONS FOR NASOLACRIMAL SYSTEM
#119ANTERIOR SEGMENT DRUG DELIVERY
#120COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION
#121COMPOSITIONS, KITS AND METHODS FOR ENHANCING THERAPEUTIC COMPLIANCE
#122MUCOADHESIVE SOLID OR SEMISOLID OCULAR DELIVERY SYSTEMS BASED ON PREACTIVATED THIOMERS
#123INTRAOCULAR PRESSURE REDUCTION WITH INTRACAMERAL BIMATOPROST IMPLANTS
#124TOPICAL COMPOSITION
#125INTRAURETHRAL MEDICATION DOSAGE FORM AND DEVICE
#126BIMATOPROST 0.01% SOLUTION COMPOSITIONS FOR THE TREATMENT OF OCULAR HYPERTENSTION
#127Ophthalmic compositions
#128PERIPHERALLY ACTING CANNABIDIOL (CBD)-CONTAINING COMPOUNDS AND USES THEREOF FOR ENHANCING FEMALE SEXUAL FUNCTION OR TREATING FEMALE SEXUAL DISORDERS
#129POLYESTERAMIDE COPOLYMERS POSSESSING HIGH GLASS TRANSITION TEMPERATURES
#130PROSTACYCLIN ANALOGUE FORMULATIONS
#131TOPICAL COMPOSITION COMPRISING A PROSTAGLANDIN ANALOGUE
#132METHODS AND COMPOSITIONS FOR TISSUE REGENERATION
#133Misoprostol dispersible tablet
#134METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS
#135COMPOSITIONS AND METHODS FOR TREATING EYES AND METHODS OF PREPARATION
#136OCULAR INSERT COMPOSITION OF A SEMI-CRYSTALLINE OR CRYSTALLINE PHARMACEUTICALLY ACTIVE AGENT
#137BIMATOPROST OCULAR SILICONE INSERTS AND METHODS OF USE THEREOF
#138Ophthalmic compositions
#139COMPOSITIONS CONTAINING ANDROGEN RECEPTOR ANTAGONISTS
#140Method for preparing a liposomal composition comprising latanoprost, and the pharmacologically active liposomal composition for ophthalmotherapy prepared by this method
#141OPHTHALMIC COMPOSITIONS
#142Methods and compositions for the treatment of hair loss
#143Methods and compositions for the treatment of hair loss
#144Methods and compositions for the treatment of hair loss
#145Treprostinil derivatives and their use in pharmaceutical compositions
#146Compositions and methods for preventing or treating muscle conditions
#147Dry powder treprostinil for the treatment of pulmonary hypertension
#148Pharmaceutical composition for preventing or treating inflammatory bowel disease comprising Tumor necrosis factor alpha inhibitor and Prostaglandin E2
#149REMEDY FOR HAIR GROWTH ENHANCING
#150METHOD FOR PREVENTING HAIR LOSS
#151LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF
#152Formulations
#153Drug-polymer conjugate
#154TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH
#155PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF
#156Methods of treating ocular diseases using polyalkylene glycol intracameral implants with polyactide travoprost particles
#157Methods for treating and Pharmaceutical compositions
#158Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
#159METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PNEUMONIA, BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND PULMONARY ARTERIAL HYPERTENSION
#160COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT
#161Compositions and Methods for increasing Reproduction Performance in Non Human Mammals Using Recombinant Luteinizing Hormone
#162METHODS FOR IMPROVING COGNITIVE FUNCTION
#163Transdermal treatment for erectile dysfunction
#164OPHTHALMIC COMPOSITION OF BIMATOPROST
#165PREVENTION OF PRETERM BIRTH (PTB) BY INHIBITION OF FKBP51
#166COMBINATION THERAPY
#167Topical testosterone (T) for promoting hair growth-containing formulations
#168INTRACAMERAL IMPLANT FOR TREATMENT OF AN OCULAR CONDITION
#169Methods and compositions for the treatment of hair loss
#170METHODS OF TREATING ISCHEMIA
#171Inhibition of thymine DNA glycosylase in the treatment of cancer
#172COATED OCULAR IMPLANTS
#173Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy
#174Methods and compositions for the treatment of hair loss
#175Lyophilized preparation of prostaglandin E1 methyl ester for injection and production and use thereof
#176TRANSDERMAL DELIVERY OF HIGH VISCOSITY BIOACTIVE AGENTS
#177Use of prostaglandin E1 methyl ester in manufacture of vasodilator
#178TREATMENT AND PREVENTION OF CLOSTRIDIUM DIFFICILE COLITIS USING MISOPROSTOL
#179Preservative removal from eye drops
#180DO stabilized pharmaceutical formulations
#181METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES
#182LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT
#183SYSTEMS AND METHODS FOR PRESERVATIVE REMOVAL FROM OPHTHALMIC FORMULATIONS COMPRISING COMPLEXING AGENTS
#184In vitro pharmacogenomic screening method for anticipating a patient's response to the treatment of ocular hypertension
#185Esters for treatment of ocular inflammatory conditions
#186LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF
#187OIL-IN-WATER METHOD FOR MAKING POLYMERIC IMPLANTS CONTAINING A HYPOTENSIVE LIPID
#188Dry powder treprostinil for the treatment of pulmonary hypertension
#189Dry powder treprostinil for the treatment of pulmonary hypertension
#190COMPOSITIONS FOR TREATING HAIR LOSS
#191METHODS OF REDUCING TYPE 2 CYTOKINE-MEDIATED INFLAMMATION USING NEUROMEDIN PEPTIDES
#192Methods and compositions for treatment of glaucoma and related conditions
#193BIOACTIVE VITAMIN COMBINATIONS
#194HYPOTENSIVE LIPID-CONTAINING BIODEGRADABLE INTRAOCULAR IMPLANTS AND RELATED IMPLANTS
#195Agent for treating or preventing glaucoma including a sulfonamide compound and another drug
#196Misoprostol dispersible tablet
#197PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE
#198Controlled release pharmaceutical formulations
#199Implants with controlled drug delivery features and methods of using same
#200COMPOSITIONS AND METHODS FOR REDUCING BODY FAT
#201Use of medications with neuroprotective properties to prevent or reduce the risk of ischemia-reperfusion injury in a subject
#202COMPOSITIONS AND METHODS FOR HAIR GROWTH
#203Exosomes and miRNA to treat glaucoma
#204DO stabilized pharmaceutical formulations
#205Use of cannabinoids in treating anti-depressant-induced female sexual dysfunction
#206Compositions for reducing hair loss and/or increasing hair regrowth
#207Opthalmic dispensing device
#208MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#209USE OF MIOTIC CHOLINERGIC SUBSTANCES AND F2a PROSTAGLANDIN ANALOGUES FOR PREVENTION AND TREATMENT OF MYOPIA
#210COMBINATION THERAPY FOR PULMONARY HYPERTENSION
#211OIL-IN-OIL EMULSIFIED POLMERIC IMPLANTS CONTAINING A HYPOTENSIVE LIPID AND RELATED METHODS
#212Compositions and Methods for Treating Ocular Diseases
#213Compositions for treating glaucoma or reducing intraocular pressure
#214Electrospun fibers for a local release of an anti-inflammatory drug and a promyelinating drug
#215Methods and compositions for the treatment of hair loss
#216Methods and compositions for the treatment of hair loss
#217Combination therapy
#218Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
#219Glaucoma Treatment Via Intracameral Ocular Implants
#220METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT
#221TOPICAL COMPOSITIONS FOR STIMULATING HAIR GROWTH
#222Nasolacrimal drainage system implants for drug therapy
#223Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties
#224Microemulsion compositions
#225HYPOTENSIVE LIPID-CONTAINING BIODEGRADABLE INTRAOCULAR IMPLANTS AND RELATED METHODS
#226METHODS FOR TREATING DISEASES ASSOCIATED WITH CILIOPATHIES
#227Anti-proliferative agents for treating PAH
#228J-SERIES PROSTAGLANDIN-ETHANOLAMIDES AS NOVEL THERAPEUTICS FOR SKIN AND/OR ORAL DISORDERS
#229Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties
#230Effective benzalkonium chloride-free bimatoprost ophthalmic compositions
#231INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS
#232Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same
#233Devices and methods for delivering a bio-active agent or bio-active agents
#234ANTERIOR SEGMENT DRUG DELIVERY
#235CHANNEL MODULATORS
#236TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH
#237METHOD TO ENHANCE TISSUE REGENERATION
#238Dry powder treprostinil for the treatment of pulmonary hypertension
#239METHOD AND COMPOSITION FOR TREATING OCULAR HYPERTENSION AND GLAUCOMA
#240DRUG THERAPY FOR PREVENTING OR TREATING GLAUCOMA
#241Drug delivery system for delivery of acid sensitivity drugs
#242Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
#243Methods and compositions for the treatment of hair loss
#244Analogs of proxisome proliferator activated receptor (PPAR) agonists and methods of using the same
#245FORMULATIONS OF KINASE INHIBITORS AND PROSTANOIDS
#246PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF
#247DUAL CAP SYSTEM FOR CONTAINER-CLOSURES TO MAINTAIN TIP STERILITY DURING SHELF STORAGE
#248NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
#249METHOD AND COMPOSITION FOR ADMINISTERING PROSTAGLANDINS
#250Microemulsion compositions
#251Injectable Hormone Formulations for Estrous Cycle Control in Mammals, its Manufacturing Process, Estrous Cycle Control and Puberty Triggering Methods, and Pregnancy Enhancement in Mammals
#252Diketopiperazine microparticles with defined specific surface areas
#253Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
#254OIL-IN-WATER METHOD FOR MAKING POLYMERIC IMPLANTS CONTAINING A HYPOTENSIVE LIPID
#255Pharmaceutical preparation containing pyridyl aminoacetic acid compound
#256COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS
#257SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION
#258COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT
#259Combination Therapy
#260Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
#261CHANNEL MODULATORS
#262OSMOTIC DRUG DELIVERY SYSTEM
#263Systems and Methods for Preservative Removal from Ophthalmic Formulations Comprising Complexing Agents
#264Channel modulators
#265Preservative-free treprostinil devices
#266Compositions and methods for treating eyes and methods of preparation
#267COMBINATION THERAPY
#268Esters for Treatment of Ocular Inflammatory Conditions
#269Pharmaceutical composition for treatment of increased intraocular pressure
#270Esters for treatment of ocular inflammatory conditions
#271MICROPARTICLE FORMULATIONS FOR DELIVERY OF ACTIVE AGENTS
#272D2O stabilized pharmaceutical formulations
#273Compositions and methods for treatment of erectile disfunction
#274Nitric oxide releasing prostaglandin derivatives for treating normal tension glaucoma
#275PHARMACEUTICAL COMPOSITIONS COMPRISING GELS AND METHODS FOR FABRICATING THEREOF
#276Compositions and methods for muscle regeneration using prostaglandin E2
#277Compositions and methods for treatment of erectile dysfunction
#278Compositions and methods for treatment of erectile disfunction
#279Punctal Plug With Active Agent
#280Combination therapy
#281Biodegradable drug-polymer conjugate
#282Drug-polymer conjugate
#283INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS
#284COMPOSITIONS FOR DELIVERING A BIO-ACTIVE AGENT OR BIO-ACTIVE AGENTS
#285AGENT FOR TREATING OR PREVENTING GLAUCOMA INCLUDING A SULFONAMIDE COMPOUND AND ANOTHER DRUG
#286Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
#287COMPOSITIONS AND METHODS FOR REDUCING BODY FAT
#288COMBINATION THERAPY FOR PULMONARY HYPERTENSION
#289Controlled release pharmaceutical formulations
#290Dry Powder Inhaler
#291TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH
#292Drug delivery system for delivery of acid sensitivity drugs
#293PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE
#294DRUG THERAPY FOR PREVENTING OR TREATING GLAUCOMA
#295NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECT AT RISK OF PRETERM DELIVERY
#296Oil-in-Oil emulsified polymeric implants containing a hypotensive lipid and related methods
#297Ophthalmic solution of bimatoprost
#298Hypotensive lipid-containing biodegradable intraocular implants and related implants
#299Nasolacrimal drainage system implants for drug therapy
#300Prevention of preterm birth (PTB) by inhibition of FKBP51